UPDATE: Walgreen Company (WAG) Tops Q2 EPS by 2c; Front-End Comps Down 2.6%

Go back to UPDATE: Walgreen Company (WAG) Tops Q2 EPS by 2c; Front-End Comps Down 2.6%

Macquarie Upgrades Walgreen (WAG) to Outperform

March 21, 2013 6:43 AM EDT

Macquarie upgraded Walgreen (NYSE: WAG) from Neutral to Outperform with a price target of $52.00 (from $36.00).

For an analyst ratings summary and ratings history on Walgreen click here. For more ratings news on Walgreen click here.

Shares of Walgreen closed at $46.02 yesterday, with a 52 week range of $28.53-$46.33.... More

Goldman Sachs Downgrades Walgreen (WAG) to Buy, Less Upside Potential

March 20, 2013 8:22 AM EDT

Goldman Sachs downgraded Walgreen (NYSE: WAG) from Conviction Buy to Buy with a price target of $50.00 (from $46.00). Analyst Matthew J. Fassler said he saw less upside in the stock now that the market increasingly appreciates WAG's association with Alliance-Boots.

"We maintain a Buy... More

Citi Upgrades Walgreen (WAG) from Sell to Buy

March 20, 2013 8:00 AM EDT

Citi upgraded Walgreen (NYSE: WAG) from Sell to Buy.

For an analyst ratings summary and ratings history on Walgreen click here. For more ratings news on Walgreen click here.

Shares of Walgreen closed at $44.74 yesterday, with a 52 week range of $28.53-$45.80.... More

JPMorgan Upgrades Walgreen (WAG) to Overweight

March 20, 2013 7:02 AM EDT

JPMorgan upgraded Walgreen (NYSE: WAG) from Neutral to Overweight with a price target of $55.00 (from $41.00).

For an analyst ratings summary and ratings history on Walgreen click here. For more ratings news on Walgreen click here.

Shares of Walgreen closed at $44.74 yesterday, with a 52 week range of $28.53-$45.80.... More

Walgreen (WAG), Alliance Boots Enter Long-Term Agreement w/ AmerisourceBergen (ABC)

March 19, 2013 6:32 AM EDT

Walgreen Company (NYSE: WAG) and Alliance Boots GmbH have entered into an innovative long-term partnership with AmerisourceBergen (NYSE: ABC).

This relationship will enable Walgreens, Alliance Boots and AmerisourceBergen to benefit from greater scale and global opportunities and work together on programs to improve service levels and efficiencies, while reducing costs and increasing patient access to pharmaceuticals. Together these three companies will help address global health care challenges by making it easier for manufacturers to bring products to market; increasing accessibility to the benefits of global sourcing and best... More